• Thu, November 11, 2021
Marc Goodman Maintained (XENE) at Buy with Increased Target to $40 on, Nov 11th, 2021
Marc Goodman of SVB Leerink, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Increased Target from $34 to $40 on, Nov 11th, 2021.
Marc has made no other calls on XENE in the last 4 months.
There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with Marc's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Marc
- Brian Abrahams of "RBC Capital" Initiated at Buy and Held Target at $43 on, Thursday, October 28th, 2021
- Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $48 on, Monday, October 4th, 2021
